Together, these results suggest that MYCN-driven tumor initiation is accompanied by early and marked upregulation of the MGS, and mitotic dysregulation could be the pathway by which MYCN shifts the premalignant neuroblast toward malignant transformation. Here, MYCN is linked to neoplasm.